Skip to site menu
Skip to page content
PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Pricing and Market Access
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Webinar Events
Webinar Events
All Webinars & Events
Events
Webinars
On-Demand Webinars
Buy Reports
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Biopharma Playbooks: Solutions at the Speed of Science
Simplifying clinical data processes
Control and confidence in clinical data management
Connecting healthcare tech with the life sciences industry
Optimizing Cell & Gene Therapy Processes
Collaboration and Expertise in Contract Analytical Chemistry
A new generation of CDMO services
Accelerating Biopharmaceutical Innovation
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
The next chapter of clinical trial services
Putting quality first in the pharma supply chain
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
Psychedelics potential set to extend beyond mental health
Magazine: Cleanroom chronicles
From Nobel to next-gen: Sweden’s quiet life sciences ascent
Pharma
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Pricing and Market Access
Latest
Sandoz CEO forecasts a Q1 or Q2 market entry for semaglutide biosimilars in Canada
Modulight secures $12m to shine precise light on neurological diseases
FDA calls for black box warning to be removed from HRT products
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Foreign Direct Investment
Latest
Delivering the Difference in Pharma
FDA halts uniQure’s plans for Huntington’s disease gene therapy
DrM, Dr. Mueller AG
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Immedica to buy Marinus Pharmaceuticals for $151m
Private equity deals in pharmaceutical in Canada remained flat in Q3 2024
Q3 2024 update: artificial intelligence related private equity activity in the pharmaceutical industry
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
Sharp Services invests $100 million in US and European facilities to increase capacity and service offerings
Low concentrations are no obstacle to detection in gas chromatography analysis
The latest regulatory updates affecting parenteral packaging
Webinar & Events
Sections
Webinar & Events
All Webinars & Events
Events
Webinars
On-Demand Webinars
Latest
24th Annual Clinical Trial Supply East Coast 2026
Rethinking IRT: Strategic Design for Smarter Trials
14th Annual Outsourcing in Clinical Trials Nordics 2026
Buy Reports
Newsletters
PT
Webinars & Events
Left
Right
All Webinars & Events
Events
Webinars
On-Demand Webinars
